164 related articles for article (PubMed ID: 37247280)
1. TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.
Datkhile KD; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2023 May; 24(5):1611-1619. PubMed ID: 37247280
[TBL] [Abstract][Full Text] [Related]
2. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
[TBL] [Abstract][Full Text] [Related]
3. Analysis of polymorphisms, promoter methylation, and mRNA expression profile of maternal and placental P53 and P21 genes in preeclamptic and normotensive pregnant women.
Harati-Sadegh M; Kohan L; Teimoori B; Mehrabani M; Salimi S
J Biomed Sci; 2019 Nov; 26(1):92. PubMed ID: 31703578
[TBL] [Abstract][Full Text] [Related]
4. Impact of Interaction between Single Nucleotide Polymorphism of XRCC1, XRCC2, XRCC3 with Tumor Suppressor Tp53 Gene Increases Risk of Breast Cancer: A Hospital Based Case-Control Study.
Datkhile KD; Gudur RA; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3065-3075. PubMed ID: 37774058
[TBL] [Abstract][Full Text] [Related]
5. Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women.
Jiang P; Liu J; Li W; Zeng X; Tang J
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):671-6. PubMed ID: 20732856
[TBL] [Abstract][Full Text] [Related]
6. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
Wang ML; Xu YX; Qian J; Wang FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
[TBL] [Abstract][Full Text] [Related]
7. p53 exon 4 (codon 72) polymorphism and exon 7 (codon 249) mutation in breast cancer patients in southern region (Madurai) of Tamil Nadu.
Vijayaraman KP; Veluchamy M; Murugesan P; Shanmugiah KP; Kasi PD
Asian Pac J Cancer Prev; 2012; 13(2):511-6. PubMed ID: 22524816
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.
Shabnaz S; Ahmed MU; Islam MS; Islam MR; Al-Mamun MM; Islam MS; Hasnat A
Tumour Biol; 2016 Jun; 37(6):7229-37. PubMed ID: 26666818
[TBL] [Abstract][Full Text] [Related]
9. Association of p21 SNPs and risk of cervical cancer among Chinese women.
Wang N; Wang S; Zhang Q; Lu Y; Wei H; Li W; Zhang S; Yin D; Ou Y
BMC Cancer; 2012 Dec; 12():589. PubMed ID: 23231583
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
[TBL] [Abstract][Full Text] [Related]
11. P53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women.
Roh JW; Kim BK; Lee CH; Kim J; Chung HH; Kim JW; Park NH; Song YS; Park SY; Kang SB
Oncol Res; 2010; 18(9):453-9. PubMed ID: 20524403
[TBL] [Abstract][Full Text] [Related]
12. Superoxide Dismutase (rs2070424, rs4880, rs2536512) and Catalase (rs794316, rs1001179) SNPs and their Association with Breast Cancer Risk: Findings from a Hospital Based Case-Control Study.
Datkhile KD; Gudur RA; Bhosale SJ; Gudur AK; Durgawale PP; Jagdale NJ; More AL; Patil SR
Asian Pac J Cancer Prev; 2024 Jan; 25(1):175-184. PubMed ID: 38285782
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of
Lotfi Garavand A; Mohammadi M; Mohammadzadeh S
Rep Biochem Mol Biol; 2020 Apr; 9(1):26-32. PubMed ID: 32821748
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic polymorphisms, mRNA expression of p53 and p21 with chronic benzene poisoning in a chinese occupational population.
Sun P; Qiu Y; Zhang Z; Wan J; Wang T; Jin X; Lan Q; Rothman N; Xia ZL
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1821-8. PubMed ID: 19505915
[TBL] [Abstract][Full Text] [Related]
15. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
[TBL] [Abstract][Full Text] [Related]
16. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
[TBL] [Abstract][Full Text] [Related]
17. TP53 and p21 (CDKN1A) polymorphisms and the risk of systemic lupus erythematosus.
Macedo JMB; Silva AL; Pinto AC; Landeira LFL; Portari EA; Santos-Rebouças CB; Klumb EM
Adv Rheumatol; 2023 Aug; 63(1):43. PubMed ID: 37605254
[TBL] [Abstract][Full Text] [Related]
18. Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism.
Gochhait S; Bukhari SI; Bairwa N; Vadhera S; Darvishi K; Raish M; Gupta P; Husain SA; Bamezai RN
Breast Cancer Res; 2007; 9(5):R71. PubMed ID: 17945002
[TBL] [Abstract][Full Text] [Related]
19. Association between the Arg72Pro Genotypes in the TP53 Gene and Ile655Val in the HER2 Gene and the Risk of Developing Breast Cancer in the Population of Amapá, Northern Brazil.
Cardoso YMN; Resque RL; Yoshio D; B Miranda AR; Secco M; Do N Rodrigues AS
Asian Pac J Cancer Prev; 2023 Jan; 24(1):157-162. PubMed ID: 36708564
[TBL] [Abstract][Full Text] [Related]
20. p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India.
Das M; Sharma SK; Sekhon GS; Mahanta J; Phukan RK; Jalan BK
Tumour Biol; 2017 May; 39(5):1010428317698384. PubMed ID: 28459370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
